German biotech firm Bluu Biosciences, the first company in Europe to specialize in the development and production of cell-based fish, announces it has closed a seed funding round at 7 million euros, less than ten months after its foundation. Bluu Biosciences is working to produce high-quality, sustainable fish products from cell cultures, to feature high nutritional value and a premium flavour profile.
Bluu Seafood: “The Technology Behind Cellular Agriculture is Still Too Abstract for Many Consumers. We Have to Take People With Us”
Bluu Seafood specialises in cultured fish. Fish fingers, fish balls and caviar have already been produced from the cells of Atlantic salmon and rainbow trout. The startup emerged from the Lübeck-based Fraunhofer Research Institution for Marine Biotechnology and Cell Technology (EMB), where co-founder Dr Sebastian Rakers was also employed for many years. Together with entrepreneur Simon Fabich, the cell and marine biologist founded Bluu Seafood (then known as Bluu Biosciences). A pilot plant has been in operation in Hamburg since 2024. Bluu Seafood has applied for authorisation for its products in Singapore and the USA. Dr Cornelius Lahme, responsible for marketing and communication at Bluu Seafood, talks to us in an interview about why the cultivation of fish is so important, what exactly the division …